Please confirm below to continue:
I confirm that I am a Health Care Professional (HCP) practicing in the United States, or acting on behalf of an HCP.
I am a Formulary Decision Maker (FDM) and/or working on behalf of a public or private payer organization to review scientific information to make drug or device selection or acquisition, formulary management, or coverage and reimbursement decisions on a population basis.
Beyond the D2 Blockade: Trace Amine-Associated Receptor 1 as a Novel TAARget in Schizophrenia
This 2-part video presents a history of trace amines and their receptions as well as evidence for TAAR1 as a potential therapeutic target in psychiatric disorders.